Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT. [electronic resource]
Producer: 20130624Description: 146-7 p. digitalISSN:- 1476-5365
- Adult
- Chelation Therapy -- adverse effects
- Deferoxamine -- adverse effects
- Drug Monitoring
- Early Termination of Clinical Trials
- Feasibility Studies
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Infusions, Intravenous
- Infusions, Subcutaneous
- Iron Chelating Agents -- administration & dosage
- Iron Overload -- drug therapy
- Leukemia, Myeloid, Acute -- complications
- Middle Aged
- Myeloablative Agonists -- adverse effects
- Myelodysplastic Syndromes -- complications
- Pilot Projects
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.